Home » Topics » BioWorld Science

BioWorld Science
RSS

Viral-MS link comes via bad memories

July 5, 2019

VenatoRx Pharmaceuticals synthesizes HBV capsid assembly modulators

July 4, 2019

Gedeon Richter divulges vasopressin V1A receptor antagonists

July 4, 2019

New PRMT5 inhibitors for cancer presented by Lupin

July 4, 2019

GlaxoSmithKline identifies new IDO1 inhibitors for HIV infection

July 4, 2019

Leo Pharma patents PDE4 inhibitors

July 4, 2019

Synergys Biotherapeutics receives NCI funding for development of anti-HER2 antibody fusion candidate

July 4, 2019

FDA grants accelerated approval to Xpovio for relapsed refractory multiple myeloma

July 4, 2019

European Commission approves Ultomiris for adults with PNH

July 4, 2019

Confo Therapeutics and DyNAbind establish GPCR drug discovery collaboration

July 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...